Global Immunoassay MarketThe global immunoassay market is expected to reach USD 45.78 billion by 2032, growing at a CAGR of 5 ...

Global Robotic Biopsy Devices MarketThe global robotic biopsy devices market has reached a valuation of USD 440.2 million in ...

D Printed Drugs MarketThe global 3D printed drugs market is estimated to generate a value of USD 307.54 million in 2022, with ...

Veterinary Orthopedic Drills MarketThe veterinary orthopedic drills market is expected to grow to USD 28.6 million in 2023, ...

Antiviral Drugs MarketThe antiviral drugs market is anticipated to experience significant growth, flourishing at an average ...

Veterinary Glucometers MarketThe veterinary glucometers market is set for robust growth, with a projected value of USD 351.3 ...

Global SPECT Scanning Services MarketThe global SPECT scanning services market is projected to secure a valuation of USD 2.1 ...

Staphylococcus aureus Testing MarketThe global Staphylococcus aureus testing market is on a steady growth trajectory, ...

DENVER, CO / ACCESSWIRE / October 14, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced Josh ...

PharmiWeb.Jobs, the leading global life sciences job board, is excited to announce the launch of its redesigned website for ...

Vestibular Testing System MarketThe vestibular testing system market is projected to be valued at USD 119.3 million in 2023, with expectations to rise to USD 202.4 million by 2033, marking a ...

AQILION AB (publ) is developing the anti-inflammatory drug candidate AQ312 for the treatment of ulcerative colitis, and presents new results from the Aqilion preclinical development program at the ...